Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial-Reference-Cited by-同舟云学术

Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial

Published:2009-02-02 Issue:6 Volume:49 Page:1847-1858
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Welzel Tania Mara,Morgan Timothy R.,Bonkovsky Herbert L.,Naishadham Deepa,Pfeiffer Ruth M.,Wright Elizabeth C.,Hutchinson Amy A.,Crenshaw Andrew T.,Bashirova Arman,Carrington Mary,Dotrang Myhanh,Sterling Richard K.,Lindsay Karen L.,Fontana Robert J.,Lee William M.,Di Bisceglie Adrian M.,Ghany Marc G.,Gretch David R.,Chanock Stephen J.,Chung Raymond T.,O'Brien Thomas R.,

Publisher

Wiley

Subject

Hepatology

Reference28 articles.

1. NIH Consensus Statement on Management of Hepatitis C: 2002;NIH Consens State Sci Statements,2002

2. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N Engl J Med,2002

3. Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1;Conjeevaram;Gastroenterology,2006

4. Predictors of response to therapy for chronic hepatitis C;Ferenci;Semin Liver Dis,2004

5. Host genetic determinants in hepatitis C virus infection;Yee;Genes Immun,2004

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of polymorphic variants of interferon receptor genes on COVID-19 severity and antibiotic resistance;Russian Journal of Infection and Immunity;2024-02-02

2. Participation of Single-Nucleotide Variants in IFNAR1 and IFNAR2 in the Immune Response against SARS-CoV-2 Infection: A Systematic Review;Pathogens;2023-11-06

3. IFNAR2 relevance in the clinical outcome of individuals with severe COVID-19;Frontiers in Immunology;2022-07-29

4. Congenital Zika Syndrome Is Associated With Interferon Alfa Receptor 1;Frontiers in Immunology;2021-11-25

5. ADAR RNA Modifications, the Epitranscriptome and Innate Immunity;Trends in Biochemical Sciences;2021-09